$90 Mn Humanized Mouse and Rat Model Market - Global Forecast to 2022

Dublin, April 16, 2018 -- The "Humanized Mouse and Rat Model Market by Type, Application & End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The humanized mouse models market is projected to reach USD 128.9 million by 2022 from USD 80.3 million in 2017, at a CAGR of 9.9% during the forecast period. The humanized rat models market is expected to reach USD 8.9 million by 2022 from USD 5.9 million in 2017, at a CAGR of 8.4% during the forecast period.

The major influencing factors driving the growth of this market are increasing number of research activities involving humanized models, growing demand for personalized medicine, increasing number of R&D activities in pharmaceutical and biotechnology companies, and continuous support in the form of investments and grants from the government and private sectors.

On the basis of type, the humanized mouse models are segmented into genetic and cell-based humanized mouse models. The cell-based humanized mouse models segment is expected to grow at the highest CAGR during the study period (2017-2022). The high growth of this segment can be attributed to the growing applications of cell-based humanized mouse models.

Furthermore, the cell-based humanized mouse models are categorized into CD34, PBMC, and BLT humanized mouse models. The CD34 humanized mouse models segment is estimated to account for the largest share and register the highest growth rate during the forecast period.

The major factors contributing the large share and high growth rate of this segment include usage of CD34 mouse models in in-vivo platforms for analyzing the safety and effectiveness of potential new drugs that can modulate the immune system. Thus, the growing application areas of CD34 models are likely to spur the market during the forecast period.

Humanized mouse models market is categorized into three end-user segments, namely, pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutions. The contract research organizations (CROs) segment of the market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the increasing number of pharmaceutical companies outsourcing their preclinical studies to contract research organizations (CROs).

Market Dynamics

Drivers

• Increasing Number of Research Activities Involving Humanized Models
• Mouse Models for Immunodeficiency Disorders
• Humanized Models for Cancer
• Mouse Models for Rare Diseases and Graft-Versus-Host Disease
• Growing Demand for Personalized Medicine
• Continuous Support in the Form of Investments and Grants From the Government and Private Sectors
• Funding/Grants By the National Institutes of Health (NIH)
• Funding/Grants Received From Other Government Bodies
• Increasing Number of R&D Activities in Pharmaceutical and Biotechnology Companies

Restraints

• High Cost of Humanized Models
• Regulations & Laws Formulated for Ethical Use of Animals
• The Animal Welfare Act (AWA)
• Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals

Opportunities

• Increased Production of Monoclonal Antibodies
• Rising Demand for Humanized Rat Models

Challenges

• Advances in Zebrafish Model Development
• Alternative Methods of Animal Testing
• Limitations of Humanized Mouse Models

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Clinical Trails & Research Studies Assessment

7 Humanized Mouse and Rat Models Market, By Type

8 Humanized Mouse Models Market, By Application

9 Humanized Mouse Models Market, By End User

10 Humanized Mouse Models Market, By Region

11 Competitive Landscape

12 Company Profiles

• Axenis
• Champions Oncology
• Charles River Laboratories
• Crown Bioscience (Subsidiary of Jsr Corporation)
• Genoway
• Harbour Antibodies (A Subsidiary of Harbour Biomed)
• Hera Biolabs
• Horizon Discovery (Sage Labs)
• Ingenious Targeting Laboratory
• Taconic Biosciences
• The Jackson Laboratory
• Trans Genic
• Vitalstar Biotechnology

For more information about this report visit https://www.researchandmarkets.com/research/dzzszh/90_mn_humanized?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Clinical Trials